scholarly journals Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 study

2017 ◽  
Vol 64 (7) ◽  
pp. 735-747 ◽  
Author(s):  
Shigeyuki Tahara ◽  
Mami Murakami ◽  
Tomomi Kaneko ◽  
Akira Shimatsu
Keyword(s):  
Japanese Patients ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Open Label ◽  
Phase 2 Study ◽  
Long Acting ◽  
Randomized Phase 2

scholarly journals Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study

2014 ◽  
Vol 25 (4) ◽  
pp. 514-521 ◽  
Author(s):  
Yoshiya Tanaka ◽  
Tsutomu Takeuchi ◽  
Hisashi Yamanaka ◽  
Hiroyuki Nakamura ◽  
Shigeyuki Toyoizumi ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Active Rheumatoid Arthritis ◽  
Japanese Patients ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Phase 2 Study ◽  
Randomized Phase 2

scholarly journals Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis

2020 ◽  
Vol 158 (3) ◽  
pp. 537-549.e10 ◽  
Author(s):  
William J. Sandborn ◽  
Marc Ferrante ◽  
Bal R. Bhandari ◽  
Elina Berliba ◽  
Brian G. Feagan ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Phase 2 Study ◽  
Randomized Phase 2

scholarly journals Long‐term efficacy and safety of bexarotene for Japanese patients with cutaneous T‐cell lymphoma: The results of a phase 2 study (B‐1201)

2019 ◽  
Vol 46 (7) ◽  
pp. 557-563 ◽  
Author(s):  
Toshihisa Hamada ◽  
Yoshiki Tokura ◽  
Makoto Sugaya ◽  
Mikio Ohtsuka ◽  
Ryoji Tsuboi ◽  
...  
Keyword(s):  
T Cell ◽  
Cell Lymphoma ◽  
Japanese Patients ◽  
T Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Term Efficacy ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document